Now available WEZLANA™

WEZLANA™ (ustekinumab-auub) is indicated for the treatment of patients 6 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. WEZLANA is indicated for the treatment of patients 6 years or older with active psoriatic arthritis.

View full prescribing information.